Literature DB >> 6137994

Neurological complications of vasculitis.

P M Moore, T R Cupps.   

Abstract

The vasculitides are a group of disorders that include the polyarteritis nodosa group of systemic necrotizing vasculitides, hypersensitivity vasculitis, Wegener's granulomatosis, lymphomatoid granulomatosis, giant cell arteritis, Behçet's disease, and isolated angiitis of the central nervous system. Classification is based on clinical, angiographic, and histological features. The frequency and distribution of neurological involvement vary with the underlying disorder and may provide the initial symptoms. Polyarteritis nodosa and Wegener's granulomatosis may affect both the central and peripheral nervous systems, whereas isolated angiitis of the central nervous system and Behçet's disease affect the central nervous system alone. Neurological dysfunction occurs in 80% of patients with polyarteritis nodosa and fewer than 10% of patients with hypersensitivity vasculitis. The mechanism of neurological dysfunction in the vasculitides is tissue ischemia. The clinical effects of ischemia vary, and symptoms may be transient or prolonged. Mononeuritis multiplex, polyneuropathy, and stroke are frequent complications, but encephalopathies, cranial neuropathies, and brachial plexopathies are seen as well. The occurrence of symptoms late in the course of a disease suggests ischemia resulting from healed, scarred vessels as well as from those that are acutely inflamed; this is the case in Takayasu's arteritis and possibly also in polyarteritis nodosa. Treatment is based on identifying and removing the sensitizing agent when possible. Wegener's granulomatosis requires therapy with cyclophosphamide; temporal arteritis, with corticosteroids. In other vasculitides a balance must be reached between the progression of the disease and the side effects of immunosuppression.

Entities:  

Mesh:

Year:  1983        PMID: 6137994     DOI: 10.1002/ana.410140202

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  A granulomatous necrotizing arteritis affecting the peripheral nervous system.

Authors:  T Evans; R Kapoor; J Jacobs; J Scadding
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

2.  Mononeuritis multiplex as a presenting feature of Wegener granulomatosis: a case report.

Authors:  R Peshin; D O'Gradaigh
Journal:  Clin Rheumatol       Date:  2006-11-18       Impact factor: 2.980

3.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

Review 4.  Primary and secondary vasculitic neuropathy.

Authors:  Gérard Said; Catherine Lacroix
Journal:  J Neurol       Date:  2005-04-05       Impact factor: 4.849

Review 5.  Neurological long-term follow-up in left atrial myxoma: are late complications frequent or rare?

Authors:  H Reichmann; R Romberg-Hahnloser; E Hofmann; T Becker; H G Mertens
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

Review 6.  Central nervous system polyarteritis nodosa.

Authors:  M R Rosenberg; M Parshley; S Gibson; R Wernick
Journal:  West J Med       Date:  1990-11

Review 7.  Causes of ischaemic stroke in the young.

Authors:  P J Martin; T P Enevoldson; P R Humphrey
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

8.  Granulomatous angiitis of the central nervous system: protean manifestations and response to treatment.

Authors:  E H Koo; E W Massey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

9.  Expression of matrix metalloproteinases in vasculitic neuropathy.

Authors:  Gunfer Gurer; Sevim Erdem; Cetin Kocaefe; Meral Ozgüç; Ersin Tan
Journal:  Rheumatol Int       Date:  2003-11-04       Impact factor: 2.631

10.  Treatable dementias.

Authors:  M E Mahler; J L Cummings; D F Benson
Journal:  West J Med       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.